From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection-Reference-Cited by-同舟云学术

From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection

Published:2021-09-15 Issue:11 Volume:20 Page:1431-1446
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Volpedo Greta¹,Huston Ryan H¹,Holcomb Erin A¹,Pacheco-Fernandez Thalia¹,Gannavaram Sreenivas²,Bhattacharya Parna²,Nakhasi Hira L²,Satoskar Abhay R¹

Affiliation:

1. Departments of Pathology and Microbiology, Wexner Medical Center, The Ohio State University, Columbus, OH, USA

2. Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

Funder

funded by National Institutes of Health, Global Health Innovation Technology Fund

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1969231

Reference243 articles.

1. Organization WH. Investing to overcome the global impact of neglected tropical diseases: third WHO report on neglected tropical diseases (World Health Organization, Geneva, 2015).

2. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern

3. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist

4. Leishmaniasis: current situation and new perspectives

5. Viszerale Leishmaniose

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules;Exploration of Drug Science;2024-09-06

2. From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization;Frontiers in Public Health;2024-07-05

3. Manufacturing and preclinical toxicity of GLP grade gene deleted attenuated Leishmania donovani parasite vaccine;Scientific Reports;2024-06-25

4. A Proteogenomic Approach to Unravel New Proteins Encoded in the Leishmania donovani (HU3) Genome;Genes;2024-06-13

5. Targeting Leishmania infantum Mannosyl-oligosaccharide glucosidase with natural products: potential pH-dependent inhibition explored through computer-aided drug design;Frontiers in Pharmacology;2024-05-30